Want to join the conversation?
Barclays analyst Felicia Hendrix questions $CCL on the kind of yield contribution it will get from six brands on the revenue management optimization program. CEO Arnold Donald says that the brands are collaborating well on the program. This will allow the company many more capabilities in terms of more timing inquiries & smaller price movements.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?